Whistleblower Law Collaborative Client Award - May 22

The Story

Whistleblower Law Collaborative LLC says one of its clients was part of a multimillion-dollar genetic testing fraud award announced May 22, 2026. The United States settled a False Claims Act case alleging genetic testing fraud involving Clarity Diagnostic Laboratories, Mercury Laboratory and multiple laboratories owned by convicted defendant Jamie McNamara, the firm said.

Why It Matters For Your Portfolio

• The settlement, described as a multimillion-dollar award, represents direct legal exposure to entities linked to Jamie McNamara, and the exact award amount was not disclosed in the release.
• The action was brought under the False Claims Act and settled by the U.S., highlighting ongoing federal enforcement in genetic testing compliance.
• Named labs include Clarity Diagnostic Laboratories and Mercury Laboratory, which investors may watch for related disclosures or regulatory follow-ups.
• Whistleblower Law Collaborative announced the result on May 22, 2026, a date investors can use to track any market or regulatory reactions tied to the news.

The Trade

This development matters most to investors tracking diagnostic and genetic testing companies and to risk-focused traders watching regulatory enforcement. Watch for corporate filings, federal enforcement updates and any disclosure from named labs that could affect sentiment and valuations. The release did not provide specific award figures, so monitor official court records for exact amounts and next steps.